Medtronic Price to Sales Ratio 2010-2025 | MDT
Historical PS ratio values for Medtronic (MDT) over the last 10 years. The current P/S ratio for Medtronic as of February 28, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Medtronic P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-02-28 | 92.02 | 3.60 | |
| 2025-01-31 | 90.82 | $25.54 | 3.56 |
| 2024-10-31 | 89.25 | $25.17 | 3.55 |
| 2024-07-31 | 79.70 | $24.63 | 3.24 |
| 2024-04-30 | 78.91 | $24.30 | 3.25 |
| 2024-01-31 | 85.39 | $24.25 | 3.52 |
| 2023-10-31 | 68.25 | $23.98 | 2.85 |
| 2023-07-31 | 84.17 | $23.68 | 3.55 |
| 2023-04-30 | 86.54 | $23.43 | 3.69 |
| 2023-01-31 | 78.94 | $23.00 | 3.43 |
| 2022-10-31 | 81.66 | $22.95 | 3.56 |
| 2022-07-31 | 85.81 | $23.05 | 3.72 |
| 2022-04-30 | 96.05 | $23.41 | 4.10 |
| 2022-01-31 | 94.69 | $23.47 | 4.03 |
| 2021-10-31 | 108.99 | $23.46 | 4.65 |
| 2021-07-31 | 118.83 | $23.33 | 5.09 |
| 2021-04-30 | 117.88 | $22.26 | 5.30 |
| 2021-01-31 | 99.75 | $20.65 | 4.83 |
| 2020-10-31 | 89.65 | $20.62 | 4.35 |
| 2020-07-31 | 85.52 | $20.67 | 4.14 |
| 2020-04-30 | 85.98 | $21.39 | 4.02 |
| 2020-01-31 | 101.07 | $22.96 | 4.40 |
| 2019-10-31 | 94.88 | $22.82 | 4.16 |
| 2019-07-31 | 88.38 | $22.62 | 3.91 |
| 2019-04-30 | 76.57 | $22.48 | 3.41 |
| 2019-01-31 | 75.80 | $22.44 | 3.38 |
| 2018-10-31 | 76.60 | $22.30 | 3.43 |
| 2018-07-31 | 76.56 | $21.96 | 3.49 |
| 2018-04-30 | 67.59 | $21.93 | 3.08 |
| 2018-01-31 | 72.45 | $21.67 | 3.34 |
| 2017-10-31 | 67.92 | $21.49 | 3.16 |
| 2017-07-31 | 70.41 | $21.60 | 3.26 |
| 2017-04-30 | 69.32 | $21.32 | 3.25 |
| 2017-01-31 | 63.09 | $20.94 | 3.01 |
| 2016-10-31 | 67.66 | $20.55 | 3.29 |
| 2016-07-31 | 71.93 | $20.21 | 3.56 |
| 2016-04-30 | 64.65 | $20.19 | 3.20 |
| 2016-01-31 | 61.70 | $21.47 | 2.87 |
| 2015-10-31 | 59.78 | $20.93 | 2.86 |
| 2015-07-31 | 63.05 | $20.38 | 3.09 |
| 2015-04-30 | 59.58 | $19.57 | 3.04 |
| 2015-01-31 | 56.91 | $17.49 | 3.25 |
| 2014-10-31 | 54.10 | $17.27 | 3.13 |
| 2014-07-31 | 48.77 | $17.03 | 2.86 |
| 2014-04-30 | 46.24 | $16.78 | 2.76 |
| 2014-01-31 | 44.27 | $16.62 | 2.66 |
| 2013-10-31 | 44.70 | $16.44 | 2.72 |
| 2013-07-31 | 42.80 | $16.27 | 2.63 |
| 2013-04-30 | 35.97 | $16.13 | 2.23 |
| 2013-01-31 | 35.71 | $15.85 | 2.25 |
| 2012-10-31 | 31.67 | $15.60 | 2.03 |
| 2012-07-31 | 29.85 | $15.40 | 1.94 |
| 2012-04-30 | 28.73 | $15.22 | 1.89 |
| 2012-01-31 | 28.83 | $14.84 | 1.94 |
| 2011-10-31 | 25.81 | $14.73 | 1.75 |
| 2011-07-31 | 26.58 | $14.54 | 1.83 |
| 2011-04-30 | 30.59 | $14.32 | 2.14 |
| 2011-01-31 | 27.91 | $14.04 | 1.99 |
| 2010-10-31 | 25.51 | $13.94 | 1.83 |
| 2010-07-31 | 26.59 | $13.79 | 1.93 |
| 2010-04-30 | 31.23 | $13.86 | 2.25 |
| 2010-01-31 | 30.52 | $13.86 | 2.20 |
| 2009-10-31 | 25.29 | $13.50 | 1.87 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $115.624B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |